Tranexamic Acid vs Niacinamide: How Each Works on Pigment, and the Evidence

Tranexamic acid vs niacinamide is less a contest than a division of labor. Tranexamic acid acts early, on the signals that switch on pigment production. Niacinamide acts late, slowing the handover of finished pigment to surrounding skin cells. Below: how each works, what the human trials measured, how strong that evidence is, and what is known about using the two together.

How does each one act on pigment?

Tranexamic acid is, first of all, a drug that limits the breakdown of blood clots. In skin, a 2026 review describes it as preventing UV-induced plasmin activation in keratinocytes, the main cells of the epidermis. Plasmin activation prompts those cells to release signals, including alpha-MSH and prostaglandin E2, that push pigment cells to make melanin. The same review links tranexamic acid to lower levels of two blood vessel growth factors, which fit one theory of how melasma develops.

Niacinamide works further downstream. In lab tests it had no effect on melanin production inside cultured pigment cells. It did block 35 to 68 percent of melanosome transfer, the step where packaged pigment moves from pigment cells into the skin cells around them. In a lab-grown skin model, it also reduced pigment.

Different steps mean different strengths. Tranexamic acid is aimed at the trigger. Niacinamide is aimed at delivery of pigment that has already been made.

Tranexamic acid vs niacinamide at a glance

	Tranexamic acid	Niacinamide
What it is	A synthetic lysine derivative, also sold as a prescription tablet	The amide form of vitamin B3
Where it acts	UV-driven plasmin signals that start pigment production	Transfer of finished pigment to skin cells
Topical strengths in trials	Mostly 2 to 5 percent	Mostly 2 to 5 percent
Best-studied use	Melasma	Uneven tone and spots, plus oil and acne
Weak point	Mixed results as a plain topical against vehicle	Small trials, some run by industry
Main caution	Redness in one topical trial	Few reactions at 2 to 5 percent

What does the tranexamic acid evidence show?

The strongest endorsement comes from a 2019 review of 35 randomized trials of topical melasma treatments. It gave tranexamic acid a strong clinical recommendation, alongside cysteamine and triple combination cream, while noting a theoretical risk of thrombosis. Look closer at plain topical products and the picture is mixed.

• In 23 women with melasma, 5 percent tranexamic acid on one side of the face was neither superior nor different from its vehicle on the other after 12 weeks. Both sides lightened, and the tranexamic acid side was redder.
• In 60 women, 5 percent tranexamic acid and 2 percent hydroquinone lowered melasma scores by similar amounts over 12 weeks, with no side effects reported in the tranexamic acid group.
• A 2024 network meta-analysis found that topical tranexamic acid separated from placebo from week 8, while the oral form did so from week 4.
• A 2024 meta-analysis of 22 trials and 1,280 patients found the largest drops with oral use, then intradermal, then topical, with high variation between studies. Treatment in those trials ran from 8 weeks to nearly 2 years. It listed stomach upset, skin irritation and menstrual changes among the reported side effects.

The oral route is a different product. Tranexamic acid tablets are a prescription drug whose US label covers heavy menstrual bleeding and warns about blood clots. Using them for melasma is a conversation for a doctor, and a serum is not a substitute. More on the mechanism is in tranexamic acid in skincare, and the comparison with the older reference drug is in tranexamic acid vs hydroquinone.

What does the niacinamide evidence show?

• A 5 percent niacinamide moisturizer reduced hyperpigmentation against vehicle after 4 weeks in 18 Japanese women. Procter & Gamble scientists led that study.
• In 27 people with melasma, 4 percent niacinamide on one side of the face and 4 percent hydroquinone on the other showed no colorimetric difference after 8 weeks. Good to excellent improvement was rated in 44 percent with niacinamide and 55 percent with hydroquinone. Side effects appeared in 18 and 29 percent.
• In 50 women over 12 weeks, 5 percent niacinamide reduced hyperpigmented spots and red blotchiness against vehicle.

Niacinamide's advantage is breadth and comfort. Its trials also cover oil output and inflammatory acne. In clinical testing reviewed by the Cosmetic Ingredient Review panel, it caused no stinging at up to 10 percent. Its weakness is depth: the pigment trials are small, and two of the three above were led by scientists from one company. Our niacinamide guide covers the ingredient itself.

What about brown marks left by acne?

Most tranexamic acid trials are in melasma. For post-inflammatory hyperpigmentation, the brown marks acne leaves behind, the evidence is thinner. One 2023 trial randomized acne patients to 5 percent tranexamic acid solution or 20 percent azelaic acid cream for 12 weeks, and 30 finished in each group. Marks improved by similar amounts in both groups, and side effects were more common with azelaic acid in the first month. There was no placebo group. These marks often fade within 6 to 12 months on their own, so the trial cannot show how much either product added.

Niacinamide appears among the depigmenting agents in a 2010 review of PIH treatment, which describes a depigmenting topical plus sunscreen as typical first-line care. In a 2025 consensus study, 62 cosmetic dermatologists agreed on niacinamide for dark spots and redness. Red or purple marks are a different problem, made of blood vessels rather than pigment, as PIE vs PIH explains.

Can you use tranexamic acid and niacinamide together?

Yes, and several products combine them. Three trials tested combinations.

• In 42 Korean women, a cream with 2 percent of each beat its vehicle over 8 weeks, with every participant using sunscreen. The first author worked at a company research center.
• In 99 people with melasma, two creams combined tranexamic acid and niacinamide, one at 2 and 2 percent and one at 5 and 4 percent. Both were as effective as 4 percent hydroquinone over three months. The hydroquinone group had more adverse reactions and relapse. The authors declared no competing interests.
• In 60 women with melasma, a serum with 5 percent niacinamide, 1 percent tranexamic acid, a vitamin C derivative and hydroxy acids performed similarly to 4 percent hydroquinone. It was also better tolerated. Two of the authors were L'Oréal employees.

None of these trials tested each ingredient alone against the pair. So they cannot tell you which one did the work, or whether the pair beats either one alone.

Does a higher percentage decide it?

No, for either one. Topical tranexamic acid trials mostly used 2 to 5 percent, and we found no trial comparing 5 percent with anything higher. A bigger number on a label is not, on its own, a reason to pay more.

For niacinamide, nearly all the efficacy data sit between 2 and 5 percent, as high-percentage niacinamide sets out in detail.

Which should you choose?

• Diagnosed or suspected melasma. See a board-certified dermatologist first. Tranexamic acid has the larger melasma trial base of the two, but plain topical results are mixed. Melasma vs hyperpigmentation explains why the diagnosis changes the plan.
• Brown marks after acne, plus oil or uneven tone. Niacinamide covers more of those jobs at once.
• Sensitive skin. Niacinamide has the more reassuring tolerance data. Topical tranexamic acid caused redness in one trial.
• One product or two. A combined product is simpler. Two separate products let you add them one at a time, so if something stings, you know which one did it.
• Either way. Wear sunscreen daily. Several trials above gave it to every participant, so the actives were measured on top of it.

Neither ingredient is worth buying for a spot that is changing in size, shape or color. That needs a dermatologist, not a serum.

Frequently asked questions

Is tranexamic acid better than niacinamide for dark spots?

For melasma, tranexamic acid has more randomized trials, though plain topical results against vehicle are mixed. For general uneven tone and marks, niacinamide has comparable small trials and better tolerance data. We found no trial comparing the two head to head as single ingredients.

Can I use tranexamic acid and niacinamide together?

Yes. They act at different steps, and two trials found combined products better tolerated than hydroquinone. None of those trials separated the two ingredients, so the combination's advantage over either alone is unproven. Add any new product on its own first.

Is topical tranexamic acid the same as the pill?

No. The tablets are a prescription drug, and their US label warns about blood clots. Oral use worked faster in melasma analyses, but it is a medical decision. A topical product is a different dose and a different route.

What percentage should I look for?

For tranexamic acid, 2 to 5 percent matches most topical trials. For niacinamide, 2 to 5 percent carries most of the evidence and the best tolerance data. We found no evidence that higher strengths of either work better.

Which is gentler on sensitive skin?

Niacinamide has the more reassuring data, with no stinging at up to 10 percent in clinical testing. Topical tranexamic acid was well tolerated in most trials, but it caused more redness than its vehicle in one 23-woman study. Patch test either one before using it on your whole face.

How long before I see a difference?

Niacinamide separated from vehicle at 4 weeks in one study. Topical tranexamic acid separated from placebo from week 8 in a 2024 analysis. Most trials ran 8 to 12 weeks with daily sunscreen, so give either about three months.